Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. - Ball,S.E.; Ahern,D.; Scatina,J.; Kao,J. (Br J Clin Pharmacol, 1997)